Table 2 Comparison of the baseline demographics of chemotherapy and best supportive care group (n = 895)
|  | Chemotherapy group (n = 519) | BSC group (n = 376) | P-value | |
|---|---|---|---|---|
Age (y) | 68.6 ± 0.5 | 76.5 ± 0.5 | <.0001 | |
Sex (Female) | 231 (44.5%) | 204 (54.3%) | <.0001 | |
Tumor location, including the pancreatic head | 269 (51.8%) | 237 (63.0%) | 0.0013 | |
Stage | I | 4 (0.8%) | 11 (2.9%) | 0.013 |
II | 7 (1.3%) | 11 (2.9%) | 0.10 | |
III | 32 (6.2%) | 25 (6.7%) | 0.77 | |
IVa | 147 (28.3%) | 85 (22.6%) | 0.064 | |
IVb | 329 (63.4%) | 244 (64.9%) | 0.64 | |
Death resulting from PC | 364 (98.1%) | 220 (92.8%) | 0.0011 | |